Related Experiment Video
Updated: Jul 29, 2025
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.3K
Cellular and Genetic Background of Osteosarcoma.
Inga Urlić1, Marijana Šimić Jovičić2, Karla Ostojić1
1Department of Biology, Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia.
Current Issues in Molecular Biology
|May 26, 2023
Summary
New sequencing technologies improve understanding of osteosarcoma (bone cancer) by revealing tumor cell populations and molecular causes. This research highlights osteosarcoma stem cells
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Osteosarcoma is a bone cancer with poor survival rates for metastatic cases.
- Targeted therapy is challenging due to tumor heterogeneity and diverse mutations.
- Current treatments show limited efficacy against metastatic osteosarcoma.
Purpose of the Study:
- To review advances in understanding osteosarcoma using new sequencing technologies.
- To explore the role of osteosarcoma stem cells in disease progression.
- To elucidate the molecular pathogenesis of osteosarcoma.
Main Methods:
- Review of recent scientific literature.
- Analysis of data from next-generation sequencing (NGS).
- Examination of single-cell sequencing (SCS) findings.
Main Results:
- New sequencing technologies offer deeper insights into osteosarcoma heterogeneity.
- Understanding of molecular pathogenesis is enhanced by advanced genomic analysis.
- Identification of osteosarcoma stem cells as key drivers of metastasis and resistance.
Conclusions:
- Next-generation sequencing and single-cell sequencing are crucial for advancing osteosarcoma research.
- Targeting osteosarcoma stem cells may offer new therapeutic strategies.
- Further research into molecular drivers is needed for improved patient outcomes.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.3K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K